Clinical Effectiveness and Feasibility of Platelet Rich Plasma Injection in Patients with Chronic Patellar Tendinopathy
- Conditions
- Jumper's Kneepatellar tendinopathy10043237
- Registration Number
- NL-OMON34982
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
• History of knee pain in the proximal section of the patellar tendon or its patellar insertion (pointed out in a anatomical drawing of the knee) in connection with training and competition
• Symptoms for over twelve months (current symptoms for at least three months)
• Age 18-40 years old
• Palpation tenderness to the corresponding painful area
• VISA score < 80
• Ultrasound characteristics showing hypoechoic zones in the corresponding area
• Recalcitrant to conservative treatment (at least eccentric training)
• acute knee or patellar tendon injuries
• chronic joint diseases
• signs or symptoms of other coexisting knee pathology
• pregnancy
• Bleeding disorders and haematological disaeses
• Malignancy
• knee surgery
• injection of any kind in the patellar tendon in the last preceding three months
• use of NSAID*S in the last 5 days before or first 6 weeks after injection or daily use of drugs with a putative effect on patellar tendinopathy in the last year (e.g. non-steroid anti-inflammatory drugs, fluorchinolones)
• actual use of anticoagulants
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Part I<br /><br>Side effects and adverse reactions/events. Experiences of the patients.<br /><br><br /><br>Part II<br /><br>Self reported VISA-P score<br /><br>The Dutch VISA-P score is a simple, reliable instrument for measuring the<br /><br>severity of patellar tendinopathy and is sensitive to small changes in<br /><br>symptoms. It was specifically designed for patellar tendinopathy, rating pain,<br /><br>symptoms, simple test of function and the ability to play sports. Six of the<br /><br>eight questions are scored on a VAS from 0 to 10 points, with 10 representing<br /><br>optimal health. The maximum VISA-P score for an asymptomatic athlete is 100<br /><br>points. The VISA-P score will be obtained for both legs separately. </p><br>
- Secondary Outcome Measures
Name Time Method